Morgan Stanley’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-20,310
| Closed | -$21K | – | 6956 |
|
2019
Q1 | $21K | Buy |
20,310
+14,446
| +246% | +$14.9K | ﹤0.01% | 6008 |
|
2018
Q4 | $4K | Sell |
5,864
-7,058
| -55% | -$4.81K | ﹤0.01% | 6361 |
|
2018
Q3 | $28K | Buy |
12,922
+590
| +5% | +$1.28K | ﹤0.01% | 6053 |
|
2018
Q2 | $29K | Buy |
12,332
+5,365
| +77% | +$12.6K | ﹤0.01% | 6062 |
|
2018
Q1 | $22K | Buy |
6,967
+850
| +14% | +$2.68K | ﹤0.01% | 6111 |
|
2017
Q4 | $25K | Sell |
6,117
-29,938
| -83% | -$122K | ﹤0.01% | 6024 |
|
2017
Q3 | $163K | Buy |
36,055
+7,476
| +26% | +$33.8K | ﹤0.01% | 5435 |
|
2017
Q2 | $95K | Sell |
28,579
-24,268
| -46% | -$80.7K | ﹤0.01% | 5657 |
|
2017
Q1 | $487K | Sell |
52,847
-56,096
| -51% | -$517K | ﹤0.01% | 4854 |
|
2016
Q4 | $840K | Buy |
108,943
+20,427
| +23% | +$158K | ﹤0.01% | 4599 |
|
2016
Q3 | $1.01M | Buy |
88,516
+63,302
| +251% | +$723K | ﹤0.01% | 4028 |
|
2016
Q2 | $311K | Buy |
25,214
+4,074
| +19% | +$50.3K | ﹤0.01% | 4710 |
|
2016
Q1 | $214K | Sell |
21,140
-129,122
| -86% | -$1.31M | ﹤0.01% | 4936 |
|
2015
Q4 | $3.39M | Buy |
150,262
+40,178
| +36% | +$906K | ﹤0.01% | 3041 |
|
2015
Q3 | $1.83M | Buy |
110,084
+6,139
| +6% | +$102K | ﹤0.01% | 3597 |
|
2015
Q2 | $2.34M | Buy |
103,945
+1,262
| +1% | +$28.4K | ﹤0.01% | 3484 |
|
2015
Q1 | $2.65M | Buy |
102,683
+8,874
| +9% | +$229K | ﹤0.01% | 3324 |
|
2014
Q4 | $2.04M | Buy |
93,809
+21,334
| +29% | +$464K | ﹤0.01% | 3545 |
|
2014
Q3 | $1.37M | Buy |
72,475
+67,514
| +1,361% | +$1.28M | ﹤0.01% | 3761 |
|
2014
Q2 | $116K | Sell |
4,961
-34,761
| -88% | -$813K | ﹤0.01% | 5432 |
|
2014
Q1 | $1.34M | Buy |
39,722
+27,978
| +238% | +$942K | ﹤0.01% | 3756 |
|
2013
Q4 | $347K | Buy |
11,744
+1,503
| +15% | +$44.4K | ﹤0.01% | 4721 |
|
2013
Q3 | $157K | Buy |
+10,241
| New | +$157K | ﹤0.01% | 4975 |
|